Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT Study

Mitotane is the only approved drug for advanced adrenocortical carcinoma (ACC) and no biomarkers are available to predict attainment of therapeutic plasma concentrations and clinical response. Aim of the study was to evaluate the suitability of cytochrome P450(CYP)2W1 and CYP2B6 single nucleotide po...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Altieri, Barbara, Sbiera, Silviu, Herterich, Sabine, De Francia, Silvia, Della Casa, Silvia, Calabrese, Anna, Pontecorvi, Alfredo, Quinkler, Marcus, Kienitz, Tina, Mannelli, Massimo, Canu, Letizia, Angelousi, Anna, Chortis, Vasileios, Kroiss, Matthias, Terzolo, Massimo, Fassnacht, Martin, Ronchi, Cristina L.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7072643/
https://ncbi.nlm.nih.gov/pubmed/32033200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12020359
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados